# XELJANZ

NDC: 63539-012
Generic name: tofacitinib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20121108

FDA application: NDA203214

## Active ingredients

- TOFACITINIB CITRATE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-012"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-012
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68e3d6b2-7838-4d2d-a417-09d919b43e13